m6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia.
m6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia.
复制标题
DOI：
10.1038/s41598-022-05797-5
复制
发表时间：
2022-02-02
影响因子：
4.6
通讯作者：
Wang X
中科院分区：
文献类型：
--
作者：
Zhong F;Yao F;Cheng Y;Liu J;Zhang N;Li S;Li M;Huang B;Wang X
Acute myeloid leukemia (AML) is a complex hematologic malignancy. Survival rate of AML patients is low. N6-methyladenosine (m6A) and long non-coding RNAs (lncRNAs) play important roles in AML tumorigenesis and progression. However, the relationship between lncRNAs and biological characteristics of AML, as well as how lncRNAs influence the prognosis of AML patients, remain unclear. In this study. In this study, Pearson correlation analysis was used to identify lncRNAs related to m6A regulatory genes, namely m6A-related lncRNAs. And we analyzed their roles and prognostic values in AML. m6A-related lncRNAs associated with patient prognosis were screened using univariate Cox regression analysis, followed by systematic analysis of the relationship between these genes and AML clinicopathologic and biologic characteristics. Furthermore, we examined the characteristics of tumor immune microenvironment (TIME) using different IncRNA clustering models. Using LASSO regression, we identified the risk signals related to prognosis of AML patients. We then constructed and verified a risk model based on m6A-related lncRNAs for independent prediction of overall survival in AML patients. Our results indicate that risk scores, calculated based on risk-related signaling, were related to the clinicopathologic characteristics of AML and level of immune infiltration. Finally, we examined the expression level of TRAF3IP2-AS1 in patient samples through real-time polymerase chain reaction analysis and in GEO datasets, and we identified a interaction relationship between SRSF10 and TRAF3IP2-AS1 through in vitro assays. Our study shows that m6A-related lncRNAs, evaluated using the risk prediction model, can potentially be used to predict prognosis and design immunotherapy in AML patients.
登录
查看更多内容
影响因子：
4.7
作者：
Lamble AJ;Lind EF
通讯作者：
Lind EF
影响因子：
21.3
作者：
Lee, Heather;Bao, Suying;Ding, Lei
通讯作者：
Ding, Lei
影响因子：
6.7
作者：
Chabrolles H;Auclair H;Vegna S;Lahlali T;Pons C;Michelet M;Couté Y;Belmudes L;Chadeuf G;Kim Y;Di Bernardo A;Jalaguier P;Cosset FL;Fusil F;Rivoire M;Arnold LD;Lopatin U;Combet C;Zoulim F;Grierson D;Chabot B;Lucifora J;Durantel D;Salvetti A
通讯作者：
Salvetti A
鉴定长非编码 RNA TRAF3IP2-AS1 作为自身免疫性疾病中通过 SRSF10-IRF1-Act1 轴的 IL-17 信号传导的关键调节剂。
影响因子：
4.4
作者：
He, Ruirui;Wu, Songfang;Wang, Chenhui
通讯作者：
Wang, Chenhui
影响因子：
5.6
作者：
Hashemi, Vida;Maleki, Leili Aghebati;Jadidi-Niaragh, Farhad
通讯作者：
Jadidi-Niaragh, Farhad